Denali Therapeutics Inc.

DNLI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017
Assets
Cash & Equivalents $218.4M
Accounts Receivable —
Inventory —
Total Current Assets $409.6M
Property, Plant & Equipment $14.9M
Goodwill —
Intangible Assets (Excl. Goodwill) —
Total Assets $486.7M
Liabilities
Accounts Payable $2.7M
Total Current Liabilities $14.2M
Long-Term Debt —
Total Liabilities $20.9M
Stockholders' Equity
Retained Earnings $-191.7M
Total Stockholders' Equity $465.8M
← Newer Page 2 of 2 Older →